Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 74Breast Neoplasms 70Rectal Neoplasms 51Stomach Neoplasms 45Glioblastoma 45Esophageal Neoplasms 42Colorectal Neoplasms 37Lung Neoplasms 35Brain Neoplasms 35Squamous Cell Carcinoma of Head and Neck 32Pancreatic Neoplasms 31Glioma 27Neoplasms 26Sarcoma 24Neoplasm Metastasis 23Astrocytoma 22Head and Neck Neoplasms 21Carcinoma, Hepatocellular 19Esophageal Squamous Cell Carcinoma 16Colonic Neoplasms 16Recurrence 15Ovarian Neoplasms 15Melanoma 15Gliosarcoma 15Central Nervous System Neoplasms 15Urinary Bladder Neoplasms 13Oligodendroglioma 13Uterine Cervical Neoplasms 12Adenocarcinoma Of Esophagus 12Prostatic Neoplasms 11

Interventions

Drug Therapy 2Cyclophosphamide 2toripalimab 1pembrolizumab 1fludarabine 1apatinib 1TP protocol 1Surgical Procedures, Operative 1Radiation 1Immunotherapy 1Heavy Ion Radiotherapy 1Doxorubicin 1Cisplatin 1Carboplatin 1AP 1903 reagent 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thymic epithelial tumor × Surgical Procedures, Operative × Clear all
NCT07383142 2026-02-06

Intrathoracic Chemotherapy for TETs With Pleural Spread or Recurrence (CHOICE-2)

Shanghai Zhongshan Hospital

Phase NA Not yet recruiting
202 enrolled

Thymic epithelial tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡